noom weight loss glp-1 Med Noom introduces longevity-focused GLP-1 microdosing

The FDA sent over 50 warning letters in September 2025 to companies doing it anyway

We do not yet know if these interventions will disrupt the bodys endocrine-regulatory process over time

47,48 These synthetic protein preparations exhibit partial or complete amino acid sequence homology with endogenous GLP-1, rendering them resistant to degradation which resulting in a prolonged half-life and heightened biological activity

PubMed , Langer, Henning Tim, et al

Danysz, W., Essmann, U., Bresink, I

The Zone-Based Rotation System Instead of randomly picking a spot each week, think in organized "zones." Each approved body region contains multiple micro-zones that you can cycle through systematically